# Safety and Pharmacokinetics of Multiple Dose of YC-6 in Healthy Subjects

> **NCT03358901** · PHASE1 · UNKNOWN · sponsor: **Guangzhou Cellprotek Pharmaceutical Co., Ltd.** · enrollment: 32 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** YC-6
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT03358901
- **Lead sponsor:** Guangzhou Cellprotek Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2017-12
- **Final completion:** 2018-01
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2017-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03358901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03358901, "Safety and Pharmacokinetics of Multiple Dose of YC-6 in Healthy Subjects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03358901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*